
Twente Medical Optics
Laser-based blood perfusion imaging technology, transforming diagnostic accuracy and flexibility for clinical applications in burn assessment, reconstructive surgery, and dermatology.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
* | N/A | Spinout | |
Total Funding | 000k |
Related Content
Twente Medical Optics is at the forefront of medical imaging innovation, introducing a new era in blood perfusion assessment with its handheld laser-based technology. By harnessing the power of Laser Doppler Imaging (LDI) and Laser Speckle Contrast Imaging (LSCI), the company has developed a device that offers unprecedented accuracy and flexibility for clinicians. Traditional blood flow imaging systems are often bulky and confined to specialized settings, but Twente Medical Optics has engineered a compact, user-friendly alternative that is currently being validated in clinical trials at leading Dutch hospitals. This technology is particularly transformative for burn diagnosis and breast flap surgeries, where precise, real-time blood flow measurements can significantly influence treatment decisions and patient recovery. The company’s patented innovations in beam shaping and compensation further enhance diagnostic reliability, setting a new standard for non-invasive perfusion imaging. With a clear focus on practical, real-world medical challenges, Twente Medical Optics is not only advancing the capabilities of healthcare professionals but also contributing to improved patient care and outcomes. Their approach exemplifies the integration of deep tech and sensor hardware into healthcare, pushing the boundaries of what is possible in medical diagnostics and supporting the broader goal of enhancing global health and well-being